Table 3.
Multivariate analysis comparing the preference in choosing FGA vs SGA drugs in the off-label subgroup
| OR [CI95%] | SIG | |
|---|---|---|
| Age | 0.979 [0.942–1.016] | 0.270 |
| Sex | 0.356 | |
| Male | (ref) | |
| Female | 0.630 [0.236–1.681] | |
| Substance Misuse | 0.271 | |
| No | (ref) | |
| Yes | 0.480 [0.130–1.774] | |
| Alcohol | 0.521 | |
| No | (ref) | |
| Yes | 1.464 [0.458–4.678] | |
| First administration | 0.359 | |
| No | (ref) | |
| Yes | 1.491 [0.502–4.430] | |
| BPRS anxiety depression | 1.102 [0.958–1.267] | 0.173 |
| BPRS anergy | 0.920 [0.791–1.070] | 0.279 |
| BPRS thought disturbances | 1.217 [1.039–1.426] | 0.015* |
| BPRS activation | 0.913 [0.731–1.140] | 0.423 |
| BPRS hostility | 0.830 [0.711–0.967] | 0.017* |
| DAI-10 total | 1.001 [0.905–1.106] | 0.987 |
| Kemp’s 7 total | 1.311 [0.896–1.919] | 0.896 |
P value of the model = 0.0358, OR Odds Ratio, IC Confidence Interval, SIG significance